Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (6946)	8/14/1998 3:14:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

To Tharos or anyone else. Is there any Biotech that has had as many collaborations on their product before approval as does Xoma with BPI? To me it is astounding to witness the amount of worldwide collaboration and study of BPI. When one studies antimicrobial peptides, where do you place BPI? I don't ever suffer hindsightitis. After research, I ask where I will be with the stock 5 to 10 years down the line. Then I buy at intervals and constantly monitor the story. You see in this way price is taken out of the picture somewhat and dips are very welcomed surprises. First and foremost though, you take for granted that ALL Biotechs are speculative and high risk. Only my opinions and good luck to us all in the next few months.